FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine; agency official says approval decision expected within two months
Pfizer and BioNTech said Friday the FDA has granted priority review designation to their application for approval of their Covid-19 vaccine, and an FDA official said the decision will come within months.
http://dlvr.it/S3sqnw
http://dlvr.it/S3sqnw
Comments
Post a Comment